skip to Main Content
Nghiem Lab
  • Research
  • People
  • Publications
  • News
  • Contact
  • Photo Gallery
  • Search
×Close search
Publications

Merkel Cell Carcinoma: An Unusually Immunogenic Cancer Proves Ripe for Immune Therapy.

Vandeven N, Nghiem P.

J Oncol Pract. 2016 Jul;12(7):649-50.

PMID: 27407162

View on PubMed - View PDF

J Oncol Pract. 2016 Jul;12(7):649-50.
Related Items
Immune checkpoint inhibitor therapy in HIV-associated Merkel cell carcinoma: A case series of 3 patients
Narrow excision margins are appropriate for Merkel cell carcinoma when combined with adjuvant radiation: Analysis of 188 cases of localized disease and proposed management algorithm
Lack of efficacy of radiation therapy plus PD-L1 blockade for Merkel cell carcinoma arising in a patient with chronic active Epstein-Barr virus infection
  • previous post: PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.
  • next post: Rationale for immune-based therapies in Merkel polyomavirus-positive and -negative Merkel cell carcinomas.
© Copyright University of Washington · Paul Nghiem Lab - All Rights Reserved 2021
Updated: Aug 22, 2018 @ 5:39 pm
Back To Top